In yesterday’s Wall Street session, Jupiter Wellness Inc. (NASDAQ:JUPW) shares traded at $0.62, down -38.81% from the previous session.
As of this writing, 1 analysts cover Jupiter Wellness Inc. (NASDAQ:JUPW). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.30 and a low of $3.30, we find $3.30. Given the previous closing price of $1.01, this indicates a potential upside of 226.73 percent. JUPW stock price is now -39.26% away from the 50-day moving average and -29.32% away from the 200-day moving average. The market capitalization of the company currently stands at $12.36M.
There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $3.30 as their price target over the next twelve months.
In other news, FANI SKENDER, Director bought 64,060 shares of the company’s stock on Oct 25. The stock was bought for $57,654 at an average price of $0.90. Upon completion of the transaction, the Director now directly owns 122,000 shares in the company, valued at $75640.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 25, Director FANI SKENDER bought 64,060 shares of the business’s stock. A total of $57,654 was incurred on buying the stock at an average price of $0.90. This leaves the insider owning 122,000 shares of the company worth $75640.0. Insiders disposed of 56,496 shares of company stock worth roughly $35027.52 over the past 1 year. A total of 23.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in JUPW stock. A new stake in Jupiter Wellness Inc. shares was purchased by MERCER GLOBAL ADVISORS INC /ADV during the first quarter worth $19,000. TRIUMPH CAPITAL MANAGEMENT invested $9,000 in shares of JUPW during the first quarter. In total, there are 22 active investors with 14.40% ownership of the company’s stock.
Thursday morning saw Jupiter Wellness Inc. (NASDAQ: JUPW) opened at $0.7900. During the past 12 months, Jupiter Wellness Inc. has had a low of $0.59 and a high of $1.64. As of last week, the company has a debt-to-equity ratio of 0.22, a current ratio of 2.80, and a quick ratio of 2.70. The fifty day moving average price for JUPW is $1.0174 and a two-hundred day moving average price translates $0.8744 for the stock.
The latest earnings results from Jupiter Wellness Inc. (NASDAQ: JUPW) was released for Jun, 2022. The company reported revenue of $1.57 million for the quarter, compared to $0.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 128.2 percent.
Jupiter Wellness Inc.(JUPW) Company Profile
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company’s clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.